What is the mortality rate of avian influenza (bird flu) in penguins at the affected locations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bird flu penguins casualty rate

There is no single, reliable “mortality rate” for penguins from H5N1 at specific locations; where confirmed, events are best described as mass-mortality clusters with high carcass counts but unknown attack rates, so assume high case fatality among clinically affected birds and plan accordingly. 1

  • What the highest-quality, recent wildlife evidence shows

    • Chile (2023, Humboldt penguins): 2,788 strandings/deaths recorded Jan–Aug 2023; 2,712 were dead. Only 4/181 tested confirmed H5N1 due to degraded samples, but spatial/temporal linkage supports H5N1-associated mass mortality. Because total exposed/infected denominator is unknown, a true mortality “rate” cannot be calculated; observed outcome is large die-offs with presumed high fatality among clinically affected penguins 1.
    • Antarctica (2024–2025): Multiple surveillance efforts near penguin colonies detected H5N1 mainly in skuas with high mortality; environmental and penguin swab RT-PCRs were negative at sampled sites, implying sporadic or low-detectable prevalence in penguins at those times, thus no calculable mortality rate for penguins there 2, 3, 4.
    • Earlier penguin studies (pre-panzootic) often found no active influenza A in colonies, underscoring that rates vary by place/time and incursion status 5.
  • How to communicate risk to stakeholders at affected locations (prioritize morbidity, mortality, QOL of colonies)

    • Treat confirmed or suspected H5N1 incursions as high-risk for rapid, localized mass mortality in penguins even when precise case fatality can’t be estimated; immediate carcass removal, access control, and biosecurity are warranted to protect colony survival and ecosystem function 1.
    • Avoid over-interpreting low RT-PCR detection in carcasses; poor sample quality commonly underestimates infection, while carcass counts better reflect impact on mortality 1.
    • In nearby predator/scavenger species (e.g., skuas), confirmed high H5N1 mortality signals ongoing viral circulation adjacent to penguin sub-colonies; escalate surveillance and protective measures for penguins at those sites 2, 3.
  • Common pitfalls and how to avoid them

    • Pitfall: Reporting “mortality rate” without a known denominator. Avoid by reporting carcass counts, timing, and lab confirmation status, clarifying that case fatality cannot be derived. Use “mass mortality event linked to H5N1” rather than a percent rate 1.
    • Pitfall: Assuming absence of virus from negative spot testing. Maintain precautionary controls; serology and predator mortality may indicate recent circulation despite negative swabs in penguins 4, 2.
  • Practical algorithm for an affected location

    • If carcasses rise above baseline and H5N1 is present regionally: declare suspected HPAI mass-mortality event; implement biosecurity, restrict access, and remove carcasses promptly; target fresh carcasses for RT-PCR to maximize confirmation yield; report counts daily. If confirmation obtained in any sympatric species (e.g., skuas), maintain heightened response in penguin colonies due to proximity risk 1, 2, 3.

Notes on human-pandemic guidelines

  • Human H5N1 guidance confirms high mortality in severe cases, justifying aggressive control posture, but does not provide wildlife mortality rates; thus, human guidelines frame risk seriousness but are not used to estimate penguin fatality percentages 6, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.